Status:
COMPLETED
EMR Referrals for Teratogen and Contraceptive Counseling for Category D or X Medication Users: RCT
Lead Sponsor:
University of California, San Diego
Conditions:
Chemical Teratogen Exposure
Contraception Behavior
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
Investigators propose a randomized controlled trial of women taking category D or X medications seen in family medicine, internal medicine or in the Coumadin Clinic. Women in the intervention group wi...
Detailed Description
Approximately 6% of pregnancies in the United States are exposed to potentially teratogenic medications. Birth defects due to prenatal exposure to teratogenic medications are among the only truly prev...
Eligibility Criteria
Inclusion
- Ethnic Background: No limitation, will include minorities and Spanish speaking participants
- Health Status: no limitation
- Sexually active with men
- Currently taking the Category D or X medication
Exclusion
- Currently Pregnant
- Not currently sexually active with men
- History of hysterectomy, bilateral oophorectomy, history of female sterilization
- Partner with history of vasectomy
Key Trial Info
Start Date :
April 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2013
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT02293213
Start Date
April 1 2012
End Date
October 1 2013
Last Update
June 7 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CTIS Pregnancy Health Information Line at the University of California San Diego
San Diego, California, United States, 92123